Largest pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Viatris has the lowest figure of the 61 pharmaceutical companies ranked by earnings, at -HK$27.6B, followed by Insmed (-HK$10B) and Summit Therapeutics (-HK$8.5B). Figures as of 18 Nov 2026, 20:50 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Viatris-HK$27.6B
- Median
- HK$462.9M
- Combined market value
- HK$39.71T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ViatrisVTRS · Health Care | -HK$27.6B | HK$182.9B | HK$159.57 | 0.54% down | 96% up | ||
| 2 | InsmedINSM · Health Care | -HK$10B | HK$206B | HK$938.93 | 1.79% down | 40% down | ||
| 3 | Summit TherapeuticsSMMT · Health Care | -HK$8.5B | HK$65.8B | HK$82.34 | 1.64% down | 36% down | ||
| 4 | Takeda PharmaceuticalTAK · Health Care | -HK$7.5B | HK$532.5B | HK$166.67 | 1.83% down | 54% up | ||
| 5 | CytokineticsCYTK · Health Care | -HK$6.2B | HK$56B | HK$402.03 | 0.78% down | 20% down | ||
| 6 | BridgeBio PharmaBBIO · Health Care | -HK$5.8B | HK$118.7B | HK$609.46 | 1.15% up | 17% up | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | -HK$3B | HK$36.1B | HK$216.84 | 2.52% up | 64% down | ||
| 8 | ABIVAXABVX · Health Care | -HK$2.9B | HK$57.5B | HK$656.53 | 1.93% up | 27% down | ||
| 9 | Jazz PharmaceuticalsJAZZ · Health Care | -HK$2.8B | HK$124B | HK$1,932.22 | 2.32% up | 37% up | ||
| 10 | Cogent BiosciencesCOGT · Health Care | -HK$2.6B | HK$37.9B | HK$217.98 | 0.23% down | 20% down | ||
| 11 | Praxis Precision MedicinesPRAX · Health Care | -HK$2.4B | HK$67.3B | HK$2,407.84 | 0.61% up | 61% up | ||
| 12 | Roivant SciencesROIV · Health Care | -HK$2.4B | HK$219.9B | HK$303.53 | 0.05% down | 90% up | ||
| 13 | Legend BiotechLEGN · Health Care | -HK$2.3B | HK$24.9B | HK$128.35 | 1.55% up | 42% down | ||
| 14 | Madrigal PharmaceuticalsMDGL · Health Care | -HK$2.3B | HK$72.2B | HK$3,106.82 | 6.16% down | 24% down | ||
| 15 | Ascendis PharmaASND · Health Care | -HK$2B | HK$139B | HK$2,118.94 | 0.41% down | 28% up | ||
| 16 | Elanco Animal HealthELAN · Health Care | -HK$1.8B | HK$105B | HK$210.10 | 3.60% up | 20% up | ||
| 17 | Rhythm PharmaceuticalsRYTM · Health Care | -HK$1.5B | HK$64.9B | HK$936.14 | 2.33% up | 13% up | ||
| 18 | Definium TherapeuticsDFTX · Health Care | -HK$1.4B | HK$31.3B | HK$228.46 | 0.88% down | 169% up | ||
| 19 | Axsome TherapeuticsAXSM · Health Care | -HK$1.4B | HK$55.1B | HK$1,047.82 | 1.76% down | 7% down | ||
| 20 | Edgewise TherapeuticsEWTX · Health Care | -HK$1.3B | HK$35.6B | HK$325.15 | 1.42% down | 88% up | ||
| 21 | Dianthus TherapeuticsDNTH · Health Care | -HK$1.3B | HK$37.1B | HK$658.30 | 3.53% down | 113% up | ||
| 22 | Spyre TherapeuticsSYRE · Health Care | -HK$1.2B | HK$75.6B | HK$796.38 | 8.21% up | 286% up | ||
| 23 | Protagonist TherapeuticsPTGX · Health Care | -HK$1B | HK$64.9B | HK$994.23 | 1.65% up | 46% up | ||
| 24 | ErascaERAS · Health Care | -HK$977.1M | HK$37.5B | HK$106.81 | 1.98% down | 403% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -HK$827.2M | HK$50.9B | HK$749.89 | 0.76% down | 241% up | ||
| 26 | Belite BioBLTE · Health Care | -HK$608.9M | HK$50.1B | HK$1,233.56 | 0.31% down | 31% up | ||
| 27 | VeradermicsMANE · Health Care | -HK$549.1M | HK$41.2B | HK$976.78 | 0.90% down | 233% up | ||
| 28 | Travere TherapeuticsTVTX · Health Care | -HK$200.4M | HK$37.7B | HK$392.74 | 2.04% down | 44% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | -HK$183.3M | HK$47.2B | HK$722.94 | 0.22% up | 31% up | ||
| 30 | Arrowhead PharmaceuticalsARWR · Health Care | -HK$12.8M | HK$47.9B | HK$338.72 | 0.43% up | 10% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | HK$462.9M | HK$58.4B | HK$743.81 | 0.32% down | 126% up | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | HK$565.3M | HK$59.7B | HK$171.26 | 3.36% up | 83% up | ||
| 33 | Corcept TherapeuticsCORT · Health Care | HK$781.8M | HK$58.2B | HK$532.07 | 3.21% down | 8% down | ||
| 34 | Ligand PharmaceuticalsLGND · Health Care | HK$976.4M | HK$46.9B | HK$2,343.86 | 1.68% up | 43% up | ||
| 35 | AlkermesALKS · Health Care | HK$1.9B | HK$61.6B | HK$366.81 | 2.87% up | 58% up | ||
| 36 | BeOne MedicinesONC · Health Care | HK$2.3B | HK$361.3B | HK$3,162.91 | 2.44% down | 17% up | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | HK$2.5B | HK$157B | HK$1,172.05 | 4.54% down | 66% down | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | HK$2.7B | HK$93.5B | HK$482.88 | 5.20% up | 11% up | ||
| 39 | GrifolsGRFS · Health Care | HK$3.5B | HK$45.2B | HK$66.41 | 1.91% down | 1% up | ||
| 40 | TG TherapeuticsTGTX · Health Care | HK$3.5B | HK$78.3B | HK$517.79 | 5.25% up | 107% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | HK$3.6B | HK$98B | HK$117.52 | 1.28% up | 5% up | ||
| 42 | PTC TherapeuticsPTCT · Health Care | HK$5.4B | HK$39.3B | HK$470.84 | 0.57% down | 20% down | ||
| 43 | Royalty PharmaRPRX · Health Care | HK$6B | HK$309.6B | HK$538.50 | 0.06% down | 78% up | ||
| 44 | GenmabGMAB · Health Care | HK$7.6B | HK$247.2B | HK$400.89 | 1.66% down | 70% up | ||
| 45 | United TherapeuticsUTHR · Health Care | HK$10.5B | HK$193.4B | HK$4,541.17 | 0.90% down | 23% up | ||
| 46 | Teva Pharmaceutical IndustriesTEVA · Health Care | HK$11.1B | HK$386.2B | HK$330.99 | 1.01% down | 74% up | ||
| 47 | ZoetisZTS · Health Care | HK$21B | HK$272.9B | HK$671.64 | 2.55% up | 29% down | ||
| 48 | Vertex PharmaceuticalsVRTX · Health Care | HK$31B | HK$1.07T | HK$4,219.05 | 0.67% up | 27% up | ||
| 49 | AbbVieABBV · Health Care | HK$33.2B | HK$3.96T | HK$2,242.54 | 2.38% down | 26% up | ||
| 50 | Regeneron PharmaceuticalsREGN · Health Care | HK$35.3B | HK$767.4B | HK$7,418.67 | 1.27% down | 36% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | HK$51.2B | HK$1.42T | HK$821.25 | 0.03% down | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | HK$55.3B | HK$955.9B | HK$467.64 | 2.84% down | 34% up | ||
| 53 | GSKGSK · Health Care | HK$59.5B | HK$764.9B | HK$381.60 | 1.22% down | 6% up | ||
| 54 | PfizerPFE · Health Care | HK$61B | HK$1.25T | HK$219.90 | 1.55% down | 14% up | ||
| 55 | SanofiSNY · Health Care | HK$68B | HK$888.3B | HK$369.95 | 0.79% down | 4% down | ||
| 56 | AstraZenecaAZN · Health Care | HK$80.2B | HK$2.18T | HK$1,402.74 | 1.90% down | 2% up | ||
| 57 | NovartisNVS · Health Care | HK$109.7B | HK$2.3T | HK$1,218.61 | 2.39% down | 25% up | ||
| 58 | Novo NordiskNVO · Health Care | HK$119.3B | HK$1.36T | HK$309.69 | 3.01% down | 17% down | ||
| 59 | Merck & CoMRK · Health Care | HK$143.2B | HK$2.66T | HK$1,080.53 | 3.93% down | 51% up | ||
| 60 | Eli LillyLLY · Health Care | HK$161.9B | HK$9.67T | HK$10,856.72 | 2.24% down | 35% up | ||
| 61 | Johnson & JohnsonJNJ · Health Care | HK$210.3B | HK$5.16T | HK$2,142.71 | 2.00% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 7.8453 HKD).
Questions and answers
Which pharmaceutical companies have the lowest earnings?
Viatris (-HK$27.6B), Insmed (-HK$10B) and Summit Therapeutics (-HK$8.5B) have the lowest earnings of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 20:50 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by earnings have a combined market value of HK$39.71T as of 18 Nov 2026, 20:50 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.